139 related articles for article (PubMed ID: 15118464)
1. Effects on aqueous flow of dorzolamide combined with either timolol or acetazolamide.
Toris CB; Zhan GL; Yablonski ME; Camras CB
J Glaucoma; 2004 Jun; 13(3):210-5. PubMed ID: 15118464
[TBL] [Abstract][Full Text] [Related]
2. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
[TBL] [Abstract][Full Text] [Related]
3. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.
Coleman AL; Lerner F; Bernstein P; Whitcup SM
Ophthalmology; 2003 Dec; 110(12):2362-8. PubMed ID: 14644719
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma.
Lorenz K; Wasielica-Poslednik J; Bell K; Renieri G; Keicher A; Ruckes C; Pfeiffer N; Thieme H
PLoS One; 2017; 12(2):e0171636. PubMed ID: 28199397
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol. Oral to Topical CAI Study Group.
Hutzelmann JE; Polis AB; Michael AJ; Adamsons IA
Acta Ophthalmol Scand; 1998 Dec; 76(6):717-22. PubMed ID: 9881560
[TBL] [Abstract][Full Text] [Related]
6. Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy.
Gulati V; Fan S; Zhao M; Maslonka MA; Gangahar C; Toris CB
Arch Ophthalmol; 2012 Jun; 130(6):677-84. PubMed ID: 22332206
[TBL] [Abstract][Full Text] [Related]
7. Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
Stewart WC; Halper LK; Johnson-Pratt L; Polis A; Hartenbaum D
J Ocul Pharmacol Ther; 2002 Jun; 18(3):211-20. PubMed ID: 12099542
[TBL] [Abstract][Full Text] [Related]
8. Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination.
Tsukamoto H; Larsson LI
Arch Ophthalmol; 2004 Feb; 122(2):190-3. PubMed ID: 14769595
[TBL] [Abstract][Full Text] [Related]
9. Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide.
Larsson LI; Alm A
Arch Ophthalmol; 1998 Jan; 116(1):19-24. PubMed ID: 9445204
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans.
Maus TL; Larsson LI; McLaren JW; Brubaker RF
Arch Ophthalmol; 1997 Jan; 115(1):45-9. PubMed ID: 9006424
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans.
Wayman L; Larsson LI; Maus T; Alm A; Brubaker R
Arch Ophthalmol; 1997 Nov; 115(11):1368-71. PubMed ID: 9366665
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
Shin DH; Feldman RM; Sheu WP;
Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
[TBL] [Abstract][Full Text] [Related]
13. Additive effect of dorzolamide on aqueous humor flow in patients receiving long-term treatment with timolol.
Wayman LL; Larsson LI; Maus TL; Brubaker RF
Arch Ophthalmol; 1998 Nov; 116(11):1438-40. PubMed ID: 9823342
[TBL] [Abstract][Full Text] [Related]
14. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
García-López A; Paczka JA; Jiménez-Román J; Hartleben C
BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.
Fechtner RD; Airaksinen PJ; Getson AJ; Lines CR; Adamsons IA;
Acta Ophthalmol Scand; 2004 Feb; 82(1):42-8. PubMed ID: 14982045
[TBL] [Abstract][Full Text] [Related]
17. Intraindividual comparison of the effects of a fixed dorzolamide-timolol combination and latanoprost on intraocular pressure after small incision cataract surgery.
Rainer G; Menapace R; Findl O; Petternel V; Kiss B; Georgopoulos M
J Cataract Refract Surg; 2001 May; 27(5):706-10. PubMed ID: 11377900
[TBL] [Abstract][Full Text] [Related]
18. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
19. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
Plummer CE; MacKay EO; Gelatt KN
Vet Ophthalmol; 2006; 9(4):245-9. PubMed ID: 16771760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
